Therapeutic outcome of unoprostone and nipradilol in patients with normal tension glaucoma.

Therapeutic outcome of unoprostone and nipradilol in patients with normal tension glaucoma. - Therapeutic outcome of unoprostone and nipradilol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011778

Enrollment

Registered

2013-09-17

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

normal tension glaucoma

Interventions

drug intervention drug intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: normal tension glaucoma

Exclusion criteria

Exclusion criteria: neuro-ophthalmic disease and chorioretinopathy patients

Design outcomes

Primary

Measure	Time frame
intraocular pressure	—

Secondary

Measure	Time frame
The incidence rate of side effect	—

Countries

Japan

Contacts

Public ContactTakayuki Kanda

National Defense Medical College Department of Ophthalmology

kankan@ndmc.ac.jp04-2995-1683

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026